← Back to Search

Best practice alert (BPA) intervention group for Prophylaxis of Preeclampsia

N/A
Recruiting
Led By A. Dhanya Mackeen, MD, MPH
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at delivery
Awards & highlights

Study Summary

This trial aims to see if using a computer tool called an electronic health record (EHR) clinical decision support tool can help healthcare providers make better recommendations for low dose aspirin use in pregnant patients at

Who is the study for?
This trial is for pregnant individuals under the care of Geisinger who are less than 28 weeks along and at high risk for preeclampsia, as determined by specific medical guidelines. It's not specified who can't join.Check my eligibility
What is being tested?
The study tests if a new alert in doctors' electronic health records increases recommendations for low dose aspirin to prevent preeclampsia in high-risk pregnancies compared to usual care.See study design
What are the potential side effects?
Since this trial focuses on the use of an electronic alert system rather than a drug or medical procedure, there are no direct side effects associated with its implementation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed between initial prenatal visit and delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed between initial prenatal visit and delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
A sensitivity analysis of the healthcare provider recommendation for low dose aspirin use in patients, specifically those who deliver after 28 weeks
Secondary outcome measures
The healthcare provider recommendation for low dose aspirin use in all randomized patients
Other outcome measures
Number of times the best practice alert fired for a patient
Patient taking low dose aspirin
Preterm delivery
+4 more

Trial Design

2Treatment groups
Active Control
Group I: Best practice alert (BPA) intervention groupActive Control1 Intervention
An electronic health record best practice alert (BPA) will alert healthcare providers to recommend low dose aspirin for pregnant patients at high-risk for preeclampsia. This alert also allows the healthcare provider to order an over-the-counter-prescription for low dose aspirin and automatically documents LDA in the patient's medication list.
Group II: Standard care groupActive Control1 Intervention
Healthcare provider's recommendation for aspirin in patients at high-risk for preeclampsia will be based on current practice (no alerts) and the healthcare provider's knowledge.

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
149 Previous Clinical Trials
1,882,813 Total Patients Enrolled
A. Dhanya Mackeen, MD, MPHPrincipal InvestigatorGeisinger Clinic
1 Previous Clinical Trials
746 Total Patients Enrolled
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top